Ricinus communis was screened for bioactive compounds and evaluated for antibacterial and antifungal activity. 16 compounds were identified in the plant extract using GC-MS. The FTIR analysis showed the presence of alkanes, alkyl halides, amines, aldehydes and alkane. The extract showed maximum antibacterial activity against Klebsiella pneumonia and maximum antifungal activity against Aspergillus flavus. The study aims to identify new potential antimicrobial compounds from plant extracts.
Ricinus communis was screened for bioactive compounds and evaluated for antibacterial and antifungal activity. 16 compounds were identified in the plant extract using GC-MS. The FTIR analysis showed the presence of alkanes, alkyl halides, amines, aldehydes and alkane. The extract showed maximum antibacterial activity against Klebsiella pneumonia and maximum antifungal activity against Aspergillus flavus. The study aims to identify new potential antimicrobial compounds from plant extracts.
This document describes a study that analyzed the secondary metabolites and antimicrobial activity of Neisseria gonorrhoeae, the bacteria that causes gonorrhea. 39 bioactive compounds were identified in the methanolic extract of N. gonorrhoeae using GC-MS analysis. The extract showed high antimicrobial activity against fungi such as Aspergillus flavus. Nerium olender was found to be very effective at inhibiting the growth of N. gonorrhoeae with a zone of inhibition of 6.800±0.24 mm. Overall, the results suggest that compounds from N. gonorrhoeae have potential as antifungal agents.
This document describes a study that analyzed the secondary metabolites and antimicrobial activity of Neisseria gonorrhoeae, the bacteria that causes gonorrhea. 39 bioactive compounds were identified in the methanolic extract of N. gonorrhoeae using GC-MS analysis. The extract showed high antimicrobial activity against fungi such as Aspergillus flavus. Nerium olender was found to be very effective at inhibiting the growth of N. gonorrhoeae with a zone of inhibition of 6.800±0.24 mm. Overall, the results suggest that compounds from N. gonorrhoeae have potential as antifungal agents.
The document analyzes secondary metabolites produced by Shegilla dysenteriae and their anti-fungal activity. GC-MS analysis identified 40 compounds in the methanolic extract including 1-Deoxy-d-mannitol and γ-Thionodecalactone. Testing showed volatile compounds from S. dysenteriae strongly inhibited the growth of Aspergillus flavus, with a zone of inhibition of 6.00±0.22 mm. Overall, the results demonstrate S. dysenteriae produces biologically active secondary metabolites with potential for development into anti-fungal drugs.
This document analyzes the secondary metabolite compounds produced by Enterobacter aerogenes and tests its anti-fungal and anti-bacterial activity. GC-MS analysis identified 27 bioactive compounds in the methanolic extract of E. aerogenes including acids, alcohols, amines, and esters. Testing showed the extract was highly effective at suppressing the growth of Candida albicans. Coriandrum sativum plant extract also showed strong anti-bacterial activity against E. aerogenes, with a zone of inhibition of 6.75±0.22 mm. The results suggest secondary metabolites of E. aerogenes have potential for development as anti-fungal and anti-bacterial drugs.
This document summarizes a study analyzing the secondary metabolites produced by Pseudomonas fluorescens using gas chromatography-mass spectrometry (GC-MS) and evaluating its anti-fungal activity. GC-MS analysis identified 24 bioactive compounds in the bacterium's methanolic extract. Testing found that volatile compounds produced by P. fluorescens strongly suppressed the growth of the fungus Trichoderma horzianum. Several medicinal plants also demonstrated high antimicrobial activity against P. fluorescens and other microbes. The study concludes that P. fluorescens produces biologically active secondary metabolites with potential for development as new antimicrobial agents.
This document describes a study that analyzed the secondary metabolites and antimicrobial activity of Neisseria gonorrhoeae, the bacteria that causes gonorrhea. 39 bioactive compounds were identified in the methanolic extract of N. gonorrhoeae using GC-MS analysis. The extract showed high antimicrobial activity against fungi such as Aspergillus flavus. Nerium olender was found to be very effective at inhibiting the growth of N. gonorrhoeae with a zone of inhibition of 6.800±0.24 mm. Overall, the results suggest that compounds from N. gonorrhoeae have potential as antifungal agents.
This document describes a study that analyzed the secondary metabolites and antimicrobial activity of Neisseria gonorrhoeae, the bacteria that causes gonorrhea. 39 bioactive compounds were identified in the methanolic extract of N. gonorrhoeae using GC-MS analysis. The extract showed high antimicrobial activity against fungi such as Aspergillus flavus. Nerium olender was found to be very effective at inhibiting the growth of N. gonorrhoeae with a zone of inhibition of 6.800±0.24 mm. Overall, the results suggest that compounds from N. gonorrhoeae have potential as antifungal agents.
The document analyzes secondary metabolites produced by Shegilla dysenteriae and their anti-fungal activity. GC-MS analysis identified 40 compounds in the methanolic extract including 1-Deoxy-d-mannitol and γ-Thionodecalactone. Testing showed volatile compounds from S. dysenteriae strongly inhibited the growth of Aspergillus flavus, with a zone of inhibition of 6.00±0.22 mm. Overall, the results demonstrate S. dysenteriae produces biologically active secondary metabolites with potential for development into anti-fungal drugs.
This document analyzes the secondary metabolite compounds produced by Enterobacter aerogenes and tests its anti-fungal and anti-bacterial activity. GC-MS analysis identified 27 bioactive compounds in the methanolic extract of E. aerogenes including acids, alcohols, amines, and esters. Testing showed the extract was highly effective at suppressing the growth of Candida albicans. Coriandrum sativum plant extract also showed strong anti-bacterial activity against E. aerogenes, with a zone of inhibition of 6.75±0.22 mm. The results suggest secondary metabolites of E. aerogenes have potential for development as anti-fungal and anti-bacterial drugs.
This document summarizes a study analyzing the secondary metabolites produced by Pseudomonas fluorescens using gas chromatography-mass spectrometry (GC-MS) and evaluating its anti-fungal activity. GC-MS analysis identified 24 bioactive compounds in the bacterium's methanolic extract. Testing found that volatile compounds produced by P. fluorescens strongly suppressed the growth of the fungus Trichoderma horzianum. Several medicinal plants also demonstrated high antimicrobial activity against P. fluorescens and other microbes. The study concludes that P. fluorescens produces biologically active secondary metabolites with potential for development as new antimicrobial agents.